Announcement of management change


 Gemseki hereby announces the appointment of Dr. Ichiro Nagata as President and CEO of Gemseki Inc. as of February 3, 2021. Ichiro currently serves as a member of the Board of Directors and Head of CEO Office at Shin Nippon Biomedical Laboratories, Ltd. (SNBL), the parent company of Gemseki. Ichiro is a medical doctor (Japan) with a global background, having been educated from high school to graduate school in the U.S. He has a depth of experience and knowledge both in science and the business aspects of the life science industry.


 As a business development platform company, Gemseki has been involved in more than 300 projects, mainly international projects. Last year, Gemseki launched an investment fund and has established a structure to support the incubation and utilization of drug candidates and technologies from multiple perspectives.


 By welcoming a President and CEO from our parent company, Gemseki will work more closely with SNBL to provide comprehensive client support in the life science industry.